Abstract
AbstractTo clarify the alterations of tau, amyloid β protein (Aβ) 1–40 and Aβ1–42(43) in the cerebrospinal fluid (CSF) that accompany normal aging and the progression of Alzheimer's disease (AD), CSF samples of 93 AD patients, 32 longitudinal subjects among these 93 AD patients, 33 patients with non‐AD dementia, 56 with other neurological diseases, and 54 normal control subjects from three independent institutes were analyzed by sensitive enzyme‐linked immunosorbent assays. Although the tau levels increased with aging, a significant elevation of tau and a correlation between the tau levels and the clinical progression were observed in the AD patients. A significant decrease of the Aβ1–42(43) levels and a significant increase of the ratio of Aβ1–40 to Aβ1–42(43) were observed in the AD patients. The longitudinal AD study showed continuous low Aβ1–42(43) levels and an increase of the ratio of Aβ1–40 to Aβ1–42(43) before the onset of AD. These findings suggest that CSF tau may increase with the clinical progression of dementia and that the alteration of the CSF level of Aβ1–42(43) and the ratio of Aβ1–40 to Aβ1–42(43) may start at early stages in AD. The assays of CSF tau, Aβ1–40, and Aβ1–42(43) provided efficient diagnostic sensitivity (71%) and specificity (83%) by using the production of tau levels and the ratio of Aβ1–40 to Aβ1–42(43), and an improvement in sensitivity (to 91%) was obtained in the longitudinal evaluation.
Bibliography
Kanai, M., Matsubara, E., Isoe, K., Urakami, K., Nakashima, K., Arai, H., Sasaki, H., Abe, K., Iwatsubo, T., Kosaka, T., Watanabe, M., Tomidokoro, Y., Shizuka, M., Mizushima, K., Nakamura, T., Igeta, Y., Ikeda, Y., Amari, M., Kawarabayashi, T., ⦠Shoji, M. (1998). Longitudinal study of cerebrospinal fluid levels of tau, Aβ1â40, and Aβ1â42(43) in Alzheimerâs disease: A study in Japan. Annals of Neurology, 44(1), 17â26. Portico.
Authors
25
- M. Kanai (first)
- E. Matsubara (additional)
- K. Isoe (additional)
- K. Urakami (additional)
- K. Nakashima (additional)
- H. Arai (additional)
- H. Sasaki (additional)
- K. Abe (additional)
- T. Iwatsubo (additional)
- T. Kosaka (additional)
- M. Watanabe (additional)
- Y. Tomidokoro (additional)
- M. Shizuka (additional)
- K. Mizushima (additional)
- T. Nakamura (additional)
- Y. Igeta (additional)
- Y. Ikeda (additional)
- M. Amari (additional)
- T. Kawarabayashi (additional)
- K. Ishiguro (additional)
- Y. Harigaya (additional)
- K. Wakabayashi (additional)
- K. Okamoto (additional)
- S. Hirai (additional)
- M. Shoji (additional)
References
51
Referenced
251
10.1016/S0006-291X(84)80190-4
10.1126/science.1439760
10.1038/359322a0
10.1006/bbrc.1996.0042
10.1126/science.1899488
10.1016/S0021-9258(18)53661-9
10.1016/0896-6273(94)90458-8
10.1074/jbc.270.13.7013
10.1016/0006-8993(95)01163-2
10.1006/bbrc.1995.1912
10.1074/jbc.271.50.32185
10.1038/325733a0
10.1016/0047-6374(88)90041-3
10.1038/349704a0
10.1038/375754a0
10.1038/376775a0
10.1002/ana.410400614
10.1038/nm0896-864
10.1016/S0896-6273(00)80230-5
10.1016/0896-6273(95)90301-1
{'key': 'e_1_2_1_22_2', 'first-page': '1823', 'article-title': 'Full‐length amyloid‐β(1‐42(43)) and amino‐terminally modified and truncated amyloid‐β42(43) deposit in diffuse plaques', 'volume': '149', 'author': 'Iwatsubo T', 'year': '1996', 'journal-title': 'Am J Pathol.'}
/ Am J Pathol. / Full‐length amyloid‐β(1‐42(43)) and amino‐terminally modified and truncated amyloid‐β42(43) deposit in diffuse plaques by Iwatsubo T (1996)10.1038/360672a0
10.1126/science.8191290
10.1038/nm0197-67
10.1038/383710a0
10.1212/WNL.41.4.479
10.1111/j.1471-4159.1993.tb09823.x
10.1016/0304-3940(95)11291-4
10.1002/ana.410380414
10.1016/0304-3940(96)12905-0
10.1212/WNL.48.3.632
10.1016/0304-3940(96)12810-X
10.1136/jnnp.59.3.280
10.1002/ana.410380413
10.1212/WNL.48.4.1118
10.1212/WNL.34.7.939
10.1093/brain/117.5.1183
10.1001/archneur.1964.00460160003001
10.1136/jnnp.57.5.594
10.1136/jnnp.47.9.953
10.1212/WNL.44.7.1240
10.1212/WNL.47.5.1113
10.1016/0022-3956(75)90026-6
10.1111/j.1749-6632.1984.tb13859.x
10.1093/clinchem/39.4.561
10.1002/ana.410360616
10.1046/j.1471-4159.1996.67020880.x
10.1002/ana.410410220
10.1016/0197-4580(95)02061-6
{'key': 'e_1_2_1_51_2', 'first-page': '173', 'article-title': "Tau proteins in cerebrospinal fluid from patients with Alzheimer's disease: a longitudinal study", 'volume': '7', 'author': 'Isoe K', 'year': '1996', 'journal-title': 'Dementia.'}
/ Dementia. / Tau proteins in cerebrospinal fluid from patients with Alzheimer's disease: a longitudinal study by Isoe K (1996)10.1002/ana.410370325
Dates
Type | When |
---|---|
Created | 20 years, 8 months ago (Jan. 1, 2005, 10:17 a.m.) |
Deposited | 1 year, 10 months ago (Oct. 28, 2023, 11:38 a.m.) |
Indexed | 2 months, 1 week ago (June 26, 2025, 2:24 p.m.) |
Issued | 27 years, 2 months ago (July 1, 1998) |
Published | 27 years, 2 months ago (July 1, 1998) |
Published Online | 20 years, 10 months ago (Oct. 8, 2004) |
Published Print | 27 years, 2 months ago (July 1, 1998) |
@article{Kanai_1998, title={Longitudinal study of cerebrospinal fluid levels of tau, Aβ1–40, and Aβ1–42(43) in Alzheimer’s disease: A study in Japan}, volume={44}, ISSN={1531-8249}, url={http://dx.doi.org/10.1002/ana.410440108}, DOI={10.1002/ana.410440108}, number={1}, journal={Annals of Neurology}, publisher={Wiley}, author={Kanai, M. and Matsubara, E. and Isoe, K. and Urakami, K. and Nakashima, K. and Arai, H. and Sasaki, H. and Abe, K. and Iwatsubo, T. and Kosaka, T. and Watanabe, M. and Tomidokoro, Y. and Shizuka, M. and Mizushima, K. and Nakamura, T. and Igeta, Y. and Ikeda, Y. and Amari, M. and Kawarabayashi, T. and Ishiguro, K. and Harigaya, Y. and Wakabayashi, K. and Okamoto, K. and Hirai, S. and Shoji, M.}, year={1998}, month=jul, pages={17–26} }